Financials
Income statement
| Fiscal date | Mar 2025 | Mar 2024 |
|---|---|---|
| Total reported revenue | — | — |
| Cost of revenue | — | — |
| Gross profit | — | — |
| Operating expense | ||
| Research & development | — | — |
| Selling general and admin | — | — |
| Other operating expenses | — | — |
| Operating income | — | — |
| Non operating interest income | ||
| Income | — | — |
| Expense | — | — |
| Other income expense | — | — |
| Pretax income | — | — |
| Tax provision | — | — |
| Net income | — | — |
| Basic EPS | 0.6 | 0.2 |
| Diluted EPS | 0.6 | 0.2 |
| Basic average shares | 11.0B | 11.0B |
| Diluted average shares | 11.0B | 11.0B |
| EBITDA | — | — |
| Net income from continuing op. | — | — |
| Minority interests | — | — |
| Preferred stock dividends | — | — |